Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment
- 1 July 2005
- journal article
- Published by Elsevier in The Lancet
- Vol. 366 (9480) , 123-128
- https://doi.org/10.1016/s0140-6736(05)66790-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCRReproduction, 2003
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experienceBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalitiesHealth Technology Assessment, 2003
- Defining the efficiency of fluorescencein situ hybridization on uncultured amniocytes on a retrospective cohort of 27407 prenatal diagnosesPrenatal Diagnosis, 2000
- Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second TrimestersNew England Journal of Medicine, 1999
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Antenatal Screening for Down's SyndromeJournal of Medical Screening, 1997
- Trisomy in humans: incidence, origin and etiologyCurrent Opinion in Genetics & Development, 1993
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992